Skip to content

Clinical trials

Phase 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Phase 3 Country / region: Czechia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20073
20123
20131
20141
20171
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Ariad Pharmaceuticals1
Bristol-Myers Squibb1
European LeukemiaNet1
III. Medizinische Klinik Mannheim1
Pfizer1
University of Jena1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive12
Leukemia6
Bone Marrow Diseases4
Leukemia, Myeloid4
Philadelphia Chromosome3
Hematologic Diseases2
Hematologic Neoplasms2
Myeloproliferative Disorders2
Neoplasms by Histologic Type2
Bronchiolitis Obliterans Syndrome1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.